【美股招股说明书】Disc Medicine Inc美股招股说明书(2025-01-23版).pdf

Medicine shortages: EFPIA proposal for action

How Off-Label Use of Medicines Drives Health-Care Use and Disability

Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors

Position on the Use of Artificial Intelligence in the Medicinal Product Lifecycle

3D MEDICINES-B二零二二年年报

Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines

Annex 1 Socio-Economic Analysis Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products

Report of the second joint meeting (hybrid) of the WHO Global Advisory Committee on Vaccine Safety and the WHO Advisory Committee on Safety of Medicinal Products, 14–16 December2022

3D MEDICINES二零二三年年报

Clearmind Medicine Inc 2025年年度报告和过渡报告